Katie Headland

Questioner
DISC Type : c

Vice President, Business Development - Europe at Axxam

United Kingdom

Overview

Katie Headland is a strategic leader in drug discovery with over 20 years of experience, currently serving as VP of Business Development at Axxam. She specializes in creating partnerships to advance programs from target validation to lead optimization, leveraging her PhD in Nutritional Biochemistry from the University of Nottingham.

There is no publicly available information regarding Katies personal life or hobbies, as her profile focuses entirely on her extensive professional background in the pharmaceutical and biotech industries.

She has co-authored several scientific publications, particularly on therapies for obesity and diabetes during her time as a preclinical project leader.

Personality Overview

Price-Sensitive

Systematic

Cautious & Analytical

They prefer to do thorough analysis of any situation.  They generally do not appreciate an overfriendly approach and prefer to stay to-the-point. While they don't hesitate to ask questions, they are generally risk-averse and tend to be late adopters.

Topics They Care About

Drug Discovery Partnerships
Her entire career is focused on delivering drug discovery solutions and building strategic partnerships with biotech and pharma companies to advance clinical candidates.
Neuroscience Programs
Actively invites discussions on how Axxam's expertise can be leveraged to accelerate neuroscience-related drug discovery programs.
Metabolic Disease Research
Previously led preclinical projects specializing in fibrosis, liver disease (NASH), diabetes, and obesity, demonstrating deep expertise in this therapeutic area.

Media Appearances

Katie has no verified media appearances

Work History

1-2026
Vice President, Business Development - Europe at Axxam
9-2025 - 1-2026
Senior Business Development Director - Drug Discovery Services at Axxam
4-2023 - 9-2025
Business Development Director - Drug Discovery Services at Sygnature Discovery
2-2021 - 4-2023
Business Development Manager - Drug Discovery Services at Sygnature Discovery
1-2018 - 3-2021
Senior Study Director at RenaSci Ltd

Education

2002 - 2006
PhD (Nutritional Biochemistry) from University of Nottingham
1998 - 2002
BSc (Hons) Biomedical Science from De Montfort University

More Information

Social Presence :

Prographics :

Exp : 20 Location : United Kingdom Job Level : Senior Designation : Vice President, Business Development - Europe at Axxam
URL has been copied!

Insights For Selling To Katie

During A Call Or A Meeting

DO's

  • Tell them that you will come back if you don’t have a good answer for a question
  • Emphasise more on facts and measurable benefits
  • Emphasize on objective proof of ROI, help them do a thorough evaluation

DONT's

  • Don’t try to be too friendly or informal with them
  • Avoid rushing them, be polite and patient
  • Don’t overhype the product/pitch, keep it measured

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Katie is

  • Ensuring that the product delivers ROI, cost-effective pricing and process compliance are very important for them.
  • Will you ever get a clear answer from Katie

  • It doesn’t come naturally to them but they can say no if they are not convinced.

Insights For Deal Planning

    How fast (or slow) will Katie move?

  • If they have the information that they need, they can move fast at making their decisions.
  • Can Katie take some risk or not?

  • They can take some risk if they are confident that they have analyzed the circumstances well.


You And Katie

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.